Erratum: Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice

Sci Rep. 2016 Jul 7:6:28124. doi: 10.1038/srep28124.
No abstract available

Publication types

  • Published Erratum